| Hyperuricemia facilitates the prediction of maternal and perinatal adverse outcome in patients with severe/superimposed preeclampsia. | |
| | |
MedLine Citation:
|
PMID: 20653406 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
OBJECTIVE: Hyperuricemia has received much attention and debate recently with regard to its utility as a marker for preeclampsia and as a predictor of adverse maternal-fetal outcome. This investigation was undertaken in patients with severe/superimposed preeclampsia to determine whether the maternal uric acid (UA) level at initial hospital admission is a useful predictor of subsequent adverse maternal and/or perinatal outcomes. METHODS: Retrospective analysis of all patients diagnosed with severe preeclampsia, superimposed preeclampsia or HELLP syndrome during 2005 at the University of Mississippi Medical Center (UMMC). Clinical and laboratory data were collected, entered and stored electronically in a password protected, secure system. RESULT: Adverse maternal outcomes occurred in 15.3% of 258 patients in the cohort. Mean UA concentration in the absence of adverse maternal outcomes was 342.6 ± 77.3 compared to 396.1 ± 117.2 μmol/l in pregnancies with complications (p<0.001). The positive likelihood ratio (LR) for adverse maternal outcome was 5.3 with UA ≥ 76.3 μmol/l and creatinine ≥ 1.0 mg/dl. LRs rose in association with other abnormal preeclampsia serum markers. Adverse perinatal outcomes occurred in 45.2% of births. The LRs for adverse perinatal outcomes remained unchanged around 1.0. Mean UA was 363.4 ± 91.0 compared to 339.0 ± 80.9 μmol/l in pregnancies without adverse outcomes (p=0.021). CONCLUSIONS: Maternal hyperuricemia is a better predictor of maternal than perinatal risk and adverse outcome. |
| | |
Authors:
|
Marc Parrish; Meredith Griffin; Racheal Morris; Marie Darby; Michelle Y Owens; James N Martin |
Related Documents
:
|
18937736 - Implementation of nice recommendation for a policy of routine antenatal anti-d prophyla... 12205026 - The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lo... 22418956 - Evaluation of placental syndecan-1 expression in early pregnancy as a predictive fetal ... 19412806 - Maternal mortality and severe morbidity from sepsis in the netherlands. 9657506 - Maternal anthropometry-based screening and pregnancy outcome: a decision analysis. 21708486 - The cellular immunobiology associated with fetal and neonatal alloimmune thrombocytopenia. |
Publication Detail:
|
Type: Journal Article Date: 2010-07-23 |
Journal Detail:
|
Title: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians Volume: 23 ISSN: 1476-4954 ISO Abbreviation: J. Matern. Fetal. Neonatal. Med. Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-11-11 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101136916 Medline TA: J Matern Fetal Neonatal Med Country: England |
Other Details:
|
Languages: eng Pagination: 1451-5 Citation Subset: IM |
Affiliation:
|
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Winfred L. Wiser Hospital for Women and Infants, University of Mississippi Medical Center, Jackson, MS 39216-4505, USA. marc7parrish@hotmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Controversies in design and interpretation of adjuvant clinical trials.
Next Document: Chromosomal abnormalities in women with premature ovarian failure.